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Osteopenia and osteoporosis are major complications of anorexia nervosa (AN). Since bone is a tissue requiring large amounts of
energy, we examined the disproportionate increase in resting energy expenditure (REE) that occurs with refeeding of AN patients
to determine if it was related to bone accretion. Thirty-seven AN patients aged 23.4±4.8years underwent a behavioralweight-gain
protocol lasting a median of 66 days; 27 remained amenorrheic, and 10 regained menses. Sixteen controls aged 25.1 ± 4.7y e a r s
were age- and % IBW matched with patients. REE was measured using a respiratory chamber-indirect calorimeter. Signiﬁcant
correlations were foundbetween REE andchanges in spine (r = 0.48,P<0.02) andleg (r = 0.43,P<0.05) BMDs in AN patients.
Further subgroup analysis of the amenorrheics revealed signiﬁcant correlation between REE and change in spine BMD (r = 0.59,
P<0.02) and higher IGF-1 after weight gain compared to controls. Amenorrheics also had lower BMDs. These ﬁndings were
absent in theregained menses group. The increasein REE seen in womenwith AN during nutritional rehabilitationmaybe related
to active bone formation,which is not as prominent when menses have returned.
1.Introduction
Anorexia nervosa (AN) is an eating disorder characterized
by severe voluntary restriction of food with resultant major
weight loss aﬀecting up to 1% of women in Western societies
[1]. Patients with AN typically have primary or secondary
amenorrhea likely due to suppression of the reproductive
axis by means of inadequate energy stores [2].
Another consequence of the decreased caloric intake in
AN patients is a consistently reported decrease in resting
energy expenditure (REE). REE, also known as resting meta-
bolic rate, represents the amount of calories required in
a 24-hour period by the body during a nonactive period.
Metabolic rate is mainly a function of the activity of lean
body mass also known as fat-free mass (FFM). Although a
reduced REE theoretically facilitates weight gain during
refeeding, REE has also been consistently found to increase
with nutritional rehabilitation, thereby potentially rendering
weight gain more diﬃcult for patients. Several small studies
have proposed explanations for this phenomenon, including
that the increase in REE is a reﬂection of lean body mass
growth [3], a reversal of the initial adaptation to malnutri-
tion [4], or a defense of low body weight [5]. Most puzzling
is that others have found the increase in REE to be dispro-
portionately greater than weight gain and deemed this clear
evidence of a strong cellular “waste” phenomenon [6]o ra n
energy drain of unknown source accounting for the use of
extra calories. One possible hypothesis is that reversal of the
metabolic consequencesof caloric restriction necessitates ac-
tivation of systems requiring energy.
Recently, bone has been recognized as a highly metabol-
ically active tissue requiring energy [7]s u c ht h a tn e wb o n e
formationisappropriatelysuppressedwithinadequatenutri-
tion. Indeed, reduction in bone mass to the degree of oste-
openia and osteoporosis has been observed in over 90% of
adolescents with AN who have been amenorrheic for more
than 6 months [8]. Despite consideration of various ther-
apies, weight restoration, which occurs prior to return of
menses, along with menstrual recovery is regarded as the
foundation of bone recovery [9]. Signiﬁcant increases of2 Journal of Osteoporosis
BMD have been noted prior to return of menses [10]w i t h
an increase in suppressed bone formation and a fall in
bone resorption. Osteocalcin and N-telopeptide (NTX), es-
tablished biochemical markers of bone formation and
resorption, respectively, have been shown to appropriately
increase and decrease, respectively, with weight recovery [10]
accompanied with a 3-4% increase in BMD in as little as
4 months. In this longitudinal study in which we examine
women with AN before and after weight normalization
and compare them with healthy female control subjects,
we propose that a substantial amount of the unexplained
increase in REE during refeeding of AN patients is channeled
towards BMD recovery such that signiﬁcant bone rebuilding
is required before energy stores become available for restora-
tion of gonadal function.
2.Materialsand Methods
2.1. Subjects. We studied 37 patients aged 23.4 ± 4.8 (range
18–36 years) with AN and 16 healthy control women aged
25.1 ± 4.7 (range 18–35 years). Patients were receiving inpa-
tient treatment on the Eating Disorders Research Unit at the
New York State Psychiatric Institute, Columbia University
Medical Center (NYSPI, CUMC). All met criteria for AN
from the 4th edition of the Diagnostic and Statistical Manual
of Mental Disorders. Subjects were recruited, screened, and
subjected to exclusion criteria as previously described [10].
The 16 healthy control women were recruited from the
New York City area and the Columbia University campus by
public advertisements. All were healthy, eumenorrheic, and
matched with patients by age and percentage of ideal body
weight (IBW) as previously described [10]. None of the
control women had a history of an eating disorder or psychi-
atric or medical illness. Potential control subjects receiving
hormonalorothermedicationsknowntoaﬀectreproductive
function or bone metabolism were excluded. All of the
control women exercised less than 3h/wk.
All subjects provided written informed consent. The
study protocol was approved by the IRB of the NYSPI,
CUMC, and St. Luke’s-Roosevelt Hospital Center. Proce-
dures were followed according to approved ethical guide-
lines.
2.2. Bone Density, Body Fat, Fat-Free Mass Index (FFMI),
and Fat-Free Mass (FFM). Spine, pelvis, leg, and total BMDs
were determined using dual energy X-ray absorptiometry
(DEXA) from a DPX scanner (Lunar Corp., Madison, WI)
using version 3.6 software. The reports from the DPX-L
scanner (GE Systems, Madison, WI) were analyzed with the
use of version 3.6 software and were used to determine
regional BMD of the hip and spine, total body bone mineral
content, and total percentage of body fat. The CVs for
BMD measurements ranged from 0.5% to 1.0% [11]. When
measured by DXA, percentage of body fat is independent of
BMD because this value is measured directly by recognized
standard means in fat depots at sites where bone is not
present [12]. FFM is calculated by the following: fat mass =
weight × fat% and FFM = weight − fat mass. FFM is also
k n o w na sl e a nb o d ym a s s[ 13]. FFMI is calculated as FFM/
height2 [14].
2.3. REE. Each subject’s REE was measured in a respiratory
chamber-indirect calorimeter. The chamber was equipped
with a high-precision gas (oxygen and carbon dioxide)
exchange measurement system. A linear state space model
converts gas exchange measurements to energy expenditure
estimates. REE was measured early in the morning, with
subjects in a fasted state for 12–15h before the experiment.
Subjects remained in the chamber for 1 h, and REE calcula-
tionswere based on the averageof3 10-minute readings after
30minutes had elapsed [15].
2.4. Biochemical Analyses. Serum osteocalcin was measured
using a human immunoradiometric assay (Immunotopics
International, San Clemente,CA)with a sensitivity of 0.5ng/
mL and an interassay CV of 5.5–6.7%. Urine NTX was
measured with the use of an enzyme-linked immunoassay
(Ostex International Inc, Seattle, WA) with a detection limit
of 20nmol bone collagen equivalent and an interassay CV
of 4.1%. Assays for estradiol, FSH, LH, PRL, testosterone,
DHEAS, T3 and T4 (both total and free), TSH, and cortisol
were performed as previously described [10]. IGF-1 was
assessed by RIA after alcohol extraction with an intra-assay
coeﬃcient of variation of 2.4–3.0% (Nichols Institute Diag-
nostics, San Juan Capistrano, CA). Leptin and total ghrelin
levelswere measured usingcommercialELISAkits(Diagnos-
tic Systems,Webster,TX).Assaysensitivity was 0.1ng/mLfor
each. Both hormones were measured in nonfasting subjects.
For leptin, the intra-assay coeﬃcient of variation was 3.6%,
and the interassay coeﬃcient of variation was 4.9%. For
ghrelin, the intra-assay coeﬃcient ofvariation was 4.9%,and
the interassay coeﬃcientof variation was 5.5%, based on ﬁve
assays. Blood and urine samples from patients were obtained
at the initiation of hospitalization and at maintenance of
weight gain to 90% IBW for ≥2 weeks except for one patient
who reached 79% IBW. Venous samples from controls and
menstruating subjects were obtained during the follicular
phase of the menstrual cycle (days 3–10) as determined by
a take-home ovulation test kit to conﬁrm ovulatory cycles.
2.5. Treatment. Treatment for patients with AN followed a
predominantly behavioral approach at the NYSPI aimed at
normalizing weight and eating. Target weight was a mini-
mumof90%IBWbasedon1959MetropolitanLifeActuarial
Tables. All but one patient reached a minimum of 90% IBW;
that patient remained amenorrheic at 79% IBW. Median
number of days of admission was 66. On admission, patients
were fed a standard hospital diet of 1800 kcal (≈55% of
energy from carbohydrates, 15% ofenergy from protein,and
30% of energy from fat), given as 3 meals/d and a snack.
Patients were observed to eat 100% of the food prescribed
and for 1h afterwards. If patients did not gain weight, calo-
ries were increased in 400-kcal increments in food or liquid
nutritional supplement (Ensure Plus; Abbott Laboratories,
Abbott Park, IL). After a 1-2wk medical stabilization period,
patients began the active weight-gain treatment phase thatJournal of Osteoporosis 3
Table 1: Age and anthropometric measures (mean ± SD).
Characteristic
Patients with AN at
admission
(n)











Agea (years) 23.4 ± 4.8 23.6 ± 4.7 23.1 ± 4.2 24.8 ± 5.8 24.8 ± 4.7
(36) (36) (26) (10) (16)
Weighta,b (kg) 41.5 ± 5.4 53.8 ± 4.7 53.6 ± 5.0 54.5 ± 3.9 56.7 ± 4.4
(37) (37) (27) (10) (16)
BMIa,b,c (kg/m2) 15.8 ± 1.6 20.4 ± 1.0 20.3 ± 1.1 20.8 ± 0.6 21.2 ± 0.9
(37) (37) (27) (10) (16)
REEa (kcal/d) 1087 ± 128 1378 ± 191 1395 ± 211 1327 ± 113 1451 ± 135
(23) (23) (17) (6) (12)
Fat free mass indexa
(kg/m2)
14.4 ± 1.3 15.5 ± 1.1 15.6 ± 1.2 15.4 ± 0.8 15.6 ± 1.0
(36) (36) (27) (9) (16)
Signiﬁcance set at P<0.05 for all comparisons and is noted in the table.
aSigniﬁcantdiﬀerence between patients with AN at admission and patients with AN at 90% IBW.
bSigniﬁcantdiﬀerence between patients with AN at 90% IBW and controls.
cSigniﬁcant diﬀerence between amenorrheics at 90% IBW and controls.
continued until patients reached 90% IBW with weight gain
rates as previously described [10]. Formal exercise was not
allowed during hospitalization although no eﬀort was made
to control for previous exercise load. Next, a 4–6wk period
of weight maintenance ensued during which patients gained
independence and transitioned to outpatient care. Mean
caloric intake on discharge was 2600kcal. No calcium or
vitamin D supplements were given.
2.6. Statistical Analysis. Data was analyzed using multiple t-
tests, and the probability level was adjusted using the Bon-
ferroni correction to compare patients at baseline and after
weight gain, those with amenorrhea, those who regained
menses, and controls. All data are expressed as mean ±
SD. We used independent and dependent t-tests to measure
diﬀerences between groups. Multiple comparisons were
made with use of the Bonferroni method, available in SPSS
software (version 12; SPSS Inc, Chicago, IL). Signiﬁcance
was set at P<0.05 for all comparisons. Initially, patients
were analyzed as one group with the use of independent
t-tests; later, menstrual status was taken into account. For
comparisonswith controls,2-factor repeated-measures anal-
ysis of variance with Bonferroni correction was conducted.
Repeated-measures analyses were performed for LH, FSH,
estradiol, testosterone, DHEAS, serum osteocalcin, urine
NTX, and leptin after a log transformation that resulted in
aS D< 20% value for each parameter. Correlations between
REE and change in BMD and between REE and FFMI were
tested using the Pearson linear correlation.
3.Results
Thirty-seven patientsand 16healthy control subjectsentered
and completed the study. Of the 37 study patients, 10
regained normal menstruation at 90% IBW. Ageand anthro-
pometric measuresareshown inTable 1.Bonemarker ,BMD ,
and hormone data are shown in Table 2.
WhentheANpatientswere refedto90%IBW,signiﬁcant
increases were observed in BMI, REE, FFMI, osteocalcin,
spine and pelvis BMDs, LH, FSH, estradiol, leptin, total
T3, and IGF-1 while cortisol and ghrelin decreased. As the
metabolic rate is a function ofmetabolically active tissues, all
of them contained in the FFM, we controlled for diﬀerences
inFFMbetweenpatientswithanorexiaand controlsbyusing
REE/FFM and REE/FFMI [16]. At 90% IBW, signiﬁcant
correlations were observed between REE and changes in
spine (r = 0.48,P<0.02)and leg (r = 0.43, P<0.05)BMDs
as shown in Figures 1 and 2, respectively. At 90% IBW, both
BMIandweightcorrelatedwithchangeinlegBMD,andtotal
T3 correlated with change in spine BMD (P<0.05). The
REE correlations with spine and leg BMDs were even more
signiﬁcant after controlling for weight gain, an important
predictor of BMD (r = 0.65, P<0.005) and (r = 0.56,
P<0.02),respectively. The correlations remained signiﬁcant
after controlling for T3. No signiﬁcant correlations were
found between REE and FFMI at baseline or at 90% IBW or
between REE and the hormonal parameters including leptin,
ghrelin, and IGF-1.
Comparison of the patients with AN at 90% IBW to
controls showed signiﬁcantly lower BMI, spine, pelvis, leg,
and total BMDs, LH, FSH, estradiol, and free T4 and higher
urine NTX and IGF-1. Osteocalcin was higher in patients
with AN but not signiﬁcantly so. In contrast to the patients
with AN, controls exhibited high correlation between REE
and FFMI (r = 0.71, P<0.01).
As a further analysis, patients were divided into two
groupsaccordingtomenstrualstatusatthetimeoftreatment
after90%IBWtesting:thosewhoremainedamenorrheic and
those who regained menses. Of note, there was no diﬀerence
in baseline weight (41.1kg versus 42.3kg, amenorrheic
versus regained menses). After weight rehabilitation, no
diﬀerences were observed between the groups in weight,
BMI, or REE, but the amenorrheic group had higher urine
NTX (P<0.02) and lower estradiol (P<0.006) than those4 Journal of Osteoporosis
Table 2 :B o n em a r k e r ,B M D ,a n dh o r m o n ed a t a( m e a n± SD).
Characteristic
Patients with AN at
admission
(n)











Osteocalcina (ng/mL) 8.1 ± 3.0 11.1 ± 5.9 11.4 ± 6.6 10.1 ± 3.6 8.7 ± 3.6
(33) (34) (25) (9) (12)
Urine NTXb,d
(nmol/mmolCr)
72.4 ± 32.7 70.9 ± 46.8 80.0 ± 50.3 45.9 ± 22.7 48.3 ± 14.4
(34) (30) (22) (8) (11)
Total BMDb,c (g/cm2) 1.05 ± 0.09 1.05 ± 0.09 1.04 ± 0.09 1.07 ± 0.06 1.13 ± 0.05
(37) (37) (27) (10) (16)
Spine BMDa,b,c
(g/cm2)
0.89 ± 0.15 0.94 ± 0.14 0.92 ± 0.14 0.98 ± 0.13 1.07 ± 0.09
(37) (37) (27) (10) (16)
Pelvis BMDa,b,c
(g/cm2)
0.91 ± 0.13 0.94 ± 0.12 0.93 ± 0.12 0.98 ± 0.09 1.07 ± 0.06
(37) (37) (27) (10) (16)
Legs BMDb,c (g/cm2) 1.10 ± 0.15 1.09 ± 0.13 1.07 ± 0.14 1.12 ± 0.09 1.19 ± 0.07
(37) (37) (27) (10) (16)
IGF-1a,c (ng/ml) 244.4 ± 103.1 343.6 ± 120.1 345.7 ± 121.4 337.6 ± 123.2 247.9 ± 76.5
(34) (35) (26) (9) (12)
Leptina (ng/ml) 2.9 ± 2.7 14.7 ± 17.8 13.1 ± 15.6 19.3 ± 23.8 11.5 ± 5.9
(28) (31) (23) (8) (10)
Ghrelina (pg/ml) 2025 ± 748 1567 ± 669 1588 ± 654 1835 ± 1213 1738 ± 542
(24) (25) (21) (4) (11)
LHa,b (mIU/ml) 1.4 ± 2.9 2.8 ± 2.8 2.5 ± 2.7 3.6 ± 3.1 4.0 ± 2.3
(30) (35) (25) (10) (13)
FSHa,b(mIU/ml) 1.8 ± 2.1 2.7 ± 1.5 2.6 ± 1.3 3.0 ± 1.8 3.9 ± 1.3
(29) (34) (24) (10) (13)
Estradiola,b,c,d (pg/ml) 23.7 ± 6.4 32.4 ± 14.0 28.2 ± 10.1 42.7 ± 17.3 52.4 ± 31.7
(32) (35) (25) (10) (14)
Testosterone (ng/dl) 76.2 ± 36.7 81.8 ± 36.7 79.3 ± 38.6 89.1 ± 31.8 63.1 ± 21.0
(26) (31) (23) (8) (16)
DHEAS (µg/dl) 153.1 ± 59.6 142.0 ± 81.1 139.8 ± 86.9 150.2 ± 59.3 175.8 ± 78.3
(25) (29) (23) (6) (16)
Cortisola (µg/dl) 20.5 ± 5.5 16.7 ± 6.3 16.6 ± 5.9 16.2 ± 7.6 12.0 ± 4.3
(24) (27) (21) (6) (10)
TSH (mIU/L) 2.0 ± 1.2 1.7 ± 1.0 1.9 ± 1.0 1.2 ± 0.4 1.9 ± 1.0
(23) (26) (21) (5) (12)
Total T3
a (ng/dl) 76.8 ± 18.3 106.0 ± 28.3 103.8 ± 27.8 113.9 ± 30.9 120.1 ± 22.9
(27) (32) (25) (7) (12)
Free T4
b (ng/dl) 1.0 ± 0.2 1.0 ± 0.2 1.0 ± 0.2 1.0 ± 0.1 1.1 ± 0.1
(27) (32) (25) (7) (12)
Signiﬁcance set at P<0.05 for all comparisons and is noted in the table.
aSigniﬁcantdiﬀerence between patients with AN at admission and patients with AN at 90% IBW.
bSigniﬁcantdiﬀerence between patients with AN at 90% IBW and controls.
cSigniﬁcant diﬀerence between amenorrheics at 90% IBW and controls.
dSigniﬁcant diﬀerence between amenorrheics at 90% IBW and regained menses at 90% IBW.
who regained menses. Osteocalcin was also highest in this
group, but not signiﬁcantly so. Compared to controls, the
amenorrheic group at 90% IBW had lower BMI (P<0.03),
estradiol (P<0.001), spine (P<0.001), pelvis (P<0.0005),
leg (P<0.008), and total (P<0.001) BMDs and higher
IGF-1 (P<0.05). Signiﬁcant correlation between REE and
change in spine BMD (r = 0.59, P<0.02) was exhibited
in the groupwho remained amenorrheic without correlation
betweenREEand change inleg BMD(P<0.09).Controlling
for weight gain was limited by the number of patients in the
group. No diﬀerence in BMI, estradiol, IGF-1, or BMDs was
exhibited in the group who regained menses compared withJournal of Osteoporosis 5
r = 0.48, P<0.02
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Figure 1: Correlation between resting metabolic rate of patients at
90%IBW and % change in spine BMD. Each circle represents the
data point of a patient.
controls, indicating near recovery of bone mass and gonadal
function. Interestingly, no signiﬁcant correlation between
R E Ea n dc h a n g e si nB M Dw a sf o u n di nt h i sg r o u p .
4.Discussion
The etiology of the increase in REE with refeeding in AN
patients has been the subject of much debate. This is the
ﬁrst report showing signiﬁcant correlations between REE
and changes in BMD with nutritional rehabilitation. This
correlation is apparent in only women who have not yet re-
gained menses, suggesting a physiologic event with bone as a
possible metabolic sink or energy drain.
Previousstudieshavenot attemptedtocorrelateREEand
FFMI in AN patients although REE was disproportionately
elevated compared to increases in lean body mass [5]. This
is the ﬁrst study to show no correlation between REE and
height-normalized FFM indices in AN patients despite high
correlation in the normal population [17]. The absence of
correlation found in our study along with the dispropor-
tionate REE elevations previously reported suggest that the
increase in REE with refeeding is not accounted for by lean
body mass but by another physiologic system undergoing
marked energy utilization.
During refeeding, the signiﬁcant correlations between
REEand changesinBMDalongwith theelevatedosteocalcin
and the increase in IGF-1 to induce bone collagen formation
suggest bone recovery from the osteopenic or osteoporotic
s t a t ea sas o u r c eo ft h ei n c r e a s e dR E E .T h eo b s e r v e dc o r r e l a -
tion of REE with change in BMD in amenorrheic subjects
with low BMDs and the lack of correlation in the group
with resumed menses and near-normal BMDs suggest that
the latter group no longer needs to channel the energy
towards bone. Indeed, whereas the group who remained
amenorrheic continued to exhibit elevated urine NTX, the
group who regained menses demonstrated normalization
of urine NTX, indicating a return to the normal state of
1000 1200 1400 1600 1800 2000
r = 0.43, P<0.05























Figure 2: Correlation between resting metabolic rate of patients at
90% IBW and % change in leg BMD. Each circle represents the data
point of a patient.
bone resorption. The recent discovery of bone remodeling
as a physiologic phenomenon requiring a large amount of
energy but serving an evolutionary advantage [7]f u r t h e r
supports the notion of bone as a metabolic sink, for the
utilization of REE for bone recovery would serve a survival
purpose. Indeed, the endocrine manifestations of AN typ-
ically result from mechanisms designed to preserve energy
[18].
Many studies relate osteopenia and osteoporosis in AN
to nutrition, but observations linking resumption of menses
to bone recovery [19–21] may be explained by the notion
that only after substantial bone recovery occurs are suﬃcient
energy stores available for gonadal recovery. The etiology of
bone loss in AN is multifactorial, and nutritional factors,
particularly IGF-1, have been recognized to likely have an
important role [22]. The dramatic increases in REE seen
with nutritional rehabilitation and weight gain appear to be
related to bone recovery. Indeed, a comprehensive study in
AN following bone indices showed the powerful anabolic
eﬀect of nutritional rehabilitation on bone [10]. However,
in this study, the authors state that menstrual resumption
was required to suppress bone resorption and allow maximal
appropriate bone recovery. Yet a quantitative eﬀect of re-
gained menses on bone mass remains unclear. In our study,
the group who regained menses had near-normal BMDs
and no correlation between REE and changes in BMD,
suggesting that the majority of bone recovery had already
occurred such that resumption of menses would not lead
to further signiﬁcant change. Instead of favorably predicting
BMD recovery, menstrual return may indicate adequate re-
placement of energy stores.
One potential regulator linking disordered eating, amen-
orrhea, and bone is leptin, a fat cell hormone disproportion-
ately lowered by fasting. Leptin thresholds have been asso-
ciated with increased gonadotropins [2] and leptin adminis-
tration withresumption ofovulationin hypothalamicamen-
orrheic women [23]. Recently, leptin receptors were also6 Journal of Osteoporosis
discoveredinbone[24],thereby providinga possible mecha-
nism for interaction between nutritional and metabolic bone
axes and resumption of menses.
Our data are consistent with other studies examining the
bone and hormonal changes that occur with refeeding in AN
[2, 9]. In this present study, however, we searched for and
found signiﬁcant correlations between REE and changes in
BMD during nutritional rehabilitation. The main limitation
was the size of the study population, for a larger sample
would allow for control of various variables while examining
correlations and would facilitate detection of diﬀerences
between those who remained amenorrheic versus those who
regained menses. Of note, it would have been interesting
to follow the bone markers of the amenorrheics at 90%
IBW to see if continuation of adequate nutritional intake
would reverse bone loss and amenorrhea, two of the many
important complications of AN [25].
In conclusion, we explore here an alternate hypothesis
of the increase in REE during refeeding of AN patients to
relate the increased energy expenditure to bone formation
such that only after substantial BMD recovery are suﬃcient
energy stores available for gonadal recovery. Bone recovery
from osteopenic and osteoporotic states may take priority
because of its survival advantage, a notion consistent with
the reproductive then bone loss that occurs in AN. Further
research is necessary to identify why one group of AN
patients recovers bone mass and menses while undergoing
the same nutritional rehabilitation as another group yet
to recover either. Nonetheless, our hypothesis that bone
recovery utilizes a vast amount of energy oﬀers the exciting
possibility that prolongednutritional rehabilitationmay lead
to recovery from osteopenia and osteoporosis and resump-
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